Sword Health has a healthy $240 million annual revenue run rate and is trusted by over 2,000 organizations globally, having helped clients generate over $1 billion in healthcare savings. CEO Virgílio Bento raised $40M in June 2025 at a $4B valuation and is targeting a next round of $50M at $5B valuation.
Cyborg Score Rationale
Sword Health is cash-flow positive with significant revenue traction, has strong competitive positioning—ranking 6th among 467 active competitors and 2nd in total funding, and recently acquired Kaia Health in January 2026 to expand its digital health platform.
Top Insights
Acquired Kaia Health in January 2026 to strengthen digital health offerings and market position
Expanding Phoenix, its AI care specialist, beyond musculoskeletal and pelvic floor care into cardiovascular, gastroenterological, and speech therapy
Raised $40M in Series E round in June 2025 bringing total funding to $494M
Despite IPO possibilities, CEO pushed timeline back significantly—stating it will be 'much later than everyone expects'
Named Competitors
Hinge Health — Digital musculoskeletal care and behavioral health platform
Accolade — Virtual care and personalized health management
Kaia Health — Digital therapeutics for chronic pain (acquired January 2026)
Recent Developments
(January 2026) Acquired Kaia Health to expand digital health capabilities
(June 2025) Raised $40M Series E at $4B valuation to fund strategic acquisitions and AI expansion
(2025) Expanded services into mental health and pelvic health segments beyond core MSK platform
Open the full interactive Sword Health report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.